At Forward, precision medicine is built on the integrated application of deep scientific insight, advanced technology, and extensive industry expertise. Our discovery platform combines structural characterization, biophysical analyses, and computational optimization to develop highly targeted therapeutics. These capabilities are enhanced by expert empirical input and iterative experimental validation, enabling the transformation of novel concepts into optimized drug candidates.

Though a emerging biotech company, Forward has consistently focused on addressing high-unmet medical needs with significant market potential. Our commitment to delivering innovative treatments for patients worldwide is demonstrated through our first two clinical-stage assets in lung cancer and breast cancer.